Can Drugs Reduce the Risk of Long COVID? What Scientists Know So Far

Argentina Noticias Noticias

Can Drugs Reduce the Risk of Long COVID? What Scientists Know So Far
Argentina Últimas Noticias,Argentina Titulares
  • 📰 sciam
  • ⏱ Reading Time:
  • 78 sec. here
  • 3 min. at publisher
  • 📊 Quality Score:
  • News: 35%
  • Publisher: 63%

Researchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms

In the early days of the COVID-19 pandemic, urologist and clinical epidemiologist Kari Tikkinen found his schedule full of cancelled surgeries, so he had some time to kill. “Do whatever you feel is most useful,” his boss at the University of Helsinki advised him. So Tikkinen threw himself into running clinical trials for COVID-19 therapies.

Debilitating symptoms Research into long COVID—which is also known as post-acute sequelae of COVID-19, and is usually defined as COVID-19 symptoms that last longer than three months—has lagged behind studies of the acute phase of infection. People who experience long COVID live with a wide array of symptoms, ranging from mild to severely debilitating. Researchers have proposed a variety of causes for the condition—from lingering viral reservoirs, to autoimmunity, to tiny blood clots.

But that still leaves too many people at risk of getting long COVID, says Altmann. “Half is not as good as I thought it would be,” he says. “I was thinking and hoping that long COVID would be a thing of the past.” These antiviral drugs are typically used to treat people with relatively mild COVID symptoms. Tikkinen and his colleagues hope to learn more about the long-term impact of treatments received by those who were hospitalized with COVID-19. His team is following up with participants in the University of Helsinki’s arm of the World Health Organization’s international COVID-19 treatment trial, called SOLIDARITY.

Small-scale trials Researchers are hoping to find out whether more treatments can reduce the risk of long COVID. A large UK-based trial called HEAL-COVID is testing two drugs that target the cardiovascular system in people who have been hospitalized with COVID-19. One, called apixaban, is an anticoagulant. The other, atorvastatin, is a cholesterol-lowering medication thought to reduce inflammation in blood vessels.

Hemos resumido esta noticia para que puedas leerla rápidamente. Si estás interesado en la noticia, puedes leer el texto completo aquí. Leer más:

sciam /  🏆 300. in US

Argentina Últimas Noticias, Argentina Titulares

Similar News:También puedes leer noticias similares a ésta que hemos recopilado de otras fuentes de noticias.

Covid-19: Two Covid-related deaths and 1,172 casesCovid-19: Two Covid-related deaths and 1,172 casesThe total number of deaths linked to Covid-19 in Northern Ireland since the start of the pandemic is 3,301.
Leer más »

Covid-19: Five Covid-related deaths and 1,204 casesCovid-19: Five Covid-related deaths and 1,204 casesThe total number of deaths linked to Covid-19 in Northern Ireland since the start of the pandemic is 3,306.
Leer más »

Welcome To The Vice Age: How Sex, Drugs And Gambling Help Americans Cope With CovidWelcome To The Vice Age: How Sex, Drugs And Gambling Help Americans Cope With CovidThe pandemic caused millions to lean in to good old-fashioned bad behavior. Two years later, business has never been better for cannabis, gaming and porn—and the high times are here to stay.
Leer más »

Can drugs reduce the risk of long COVID? What scientists know so farResearchers are trying to establish whether existing COVID-19 vaccines and treatments can prevent lasting symptoms.
Leer más »

ADPH doctor explains CDC’s new COVID-19 calculatorADPH doctor explains CDC’s new COVID-19 calculatorThe Centers for Disease Control and Prevention has created a new quarantine and isolation calculator to give folks an easier way of figuring out when it is beneficial to stay at home.
Leer más »

Deaths Outpaced Births In A Record 73% Of U.S. Counties In 2021 As Covid RagedDeaths Outpaced Births In A Record 73% Of U.S. Counties In 2021 As Covid RagedIn a reversal of historical trends, Americans moved from larger, more populated areas to smaller and less populated ones, with 65.6% of counties reporting net positive domestic migration for 2021, the Census Bureau reported.
Leer más »



Render Time: 2025-04-08 09:15:26